[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:gastrointestinal-stromal-tumor:pdgfra-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Gastrointestinal Stromal Tumor","PDGFRA Gene",6,[8,16,23,30,36,42],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07218926","A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy",[12],"Phase 3","RECRUITING","2026-08-26T02:17:21.315591Z","2026-07-05T05:32:16.663184Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06630234","A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)",[20],"Phase 1\u002FPhase 2","2026-08-26T02:16:42.787115Z","2026-05-05T02:43:29.051332Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT07406633","KQB198 in Combination With Imatinib in Participants With Advanced\u002FMetastatic GIST in 1st Line Setting",[27],"Phase 2","2026-08-26T02:15:48.613507Z","2026-05-05T02:43:27.814895Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT05493215","Imatinib TDM in GIST",[27],"2026-08-26T02:18:19.586423Z","2026-05-05T02:43:27.434422Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT05957367","A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies",[20],"2026-08-26T02:16:36.513735Z","2026-05-05T02:43:26.929806Z",{"nct_id":43,"title":44,"phases":45,"status":47,"updated_at":48,"content_modified":49},"NCT05489237","First-in-human Study of IDRX-42 in Participants With Metastatic and\u002For Unresectable Gastrointestinal Stromal Tumors",[46],"Phase 1","ACTIVE_NOT_RECRUITING","2026-08-03T03:33:02.530589Z","2026-05-05T02:43:29.679210Z"]